• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期疟疾间歇性筛查和治疗与间歇性预防治疗的比较:用户可接受性。

Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability.

机构信息

Department of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK.

出版信息

Malar J. 2010 Jan 14;9:18. doi: 10.1186/1475-2875-9-18.

DOI:10.1186/1475-2875-9-18
PMID:20074372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2817700/
Abstract

BACKGROUND

Malaria in pregnancy is associated with increased risks of maternal and foetal complications. Currently, intermittent preventive treatment (IPT) of malaria during pregnancy with sulphadoxine-pyrimethamine (SP) is recommended by the WHO as part of a package of interventions also including insecticide-treated nets and effective case management. However, with increasing resistance to SP, the effectiveness of SP-IPT has been questioned. A randomized controlled trial (RCT) to investigate the relative efficacy of an alternative strategy of intermittent screening and treatment (IST), which involves a rapid diagnostic test for malaria at scheduled ANC visits and treatment of women only if positive, versus SP-IPT has been conducted in Ashanti region, Ghana. This paper reports on a complementary study investigating the acceptability of the different strategies to women enrolled in the trial.

METHODS

Data were collected through twelve focus group discussions with women selected at random from the different arms of the RCT, exploring their experiences and perceptions about antenatal care and their involvement in the trial. Content analysis was used to identify relevant themes to structure the results.

RESULTS

Five main themes emerged from participants' experiences of ANC and the RCT that would influence their acceptability of malaria prevention strategies during pregnancy: health benefits; drugs received; tests received; other services received; and health worker attitude. Their own health and that of their baby were strong motivations for attending ANC, and reported favourably as an outcome of being in the RCT. Women were not always clear on the biomedical function of drugs or blood tests but generally accepted them due to strong trust in the health staff. Home visits by staff and free ITNs as part of the trial were appreciated. Politeness and patience of health staff was a very strong positive factor.

CONCLUSIONS

Overall, both intermittent screening and treatment and intermittent preventive treatment appeared equally acceptable to pregnant women as strategies for the control of malaria in pregnancy. The women were more concerned about quality of services received, in particular the polite and patient attitude of health staff, and positive health implications for themselves and their babies than about the nature of the intervention.

摘要

背景

妊娠疟疾会增加母婴并发症的风险。目前,世卫组织建议在妊娠期间采用磺胺多辛-乙胺嘧啶(SP)间歇性预防治疗(IPT),作为包括驱虫蚊帐和有效病例管理在内的干预措施包的一部分。然而,随着对 SP 的耐药性增加,SP-IPT 的有效性受到了质疑。一项在加纳阿散蒂地区开展的、针对替代策略(即间歇性筛查和治疗策略,简称 IST)的相对疗效的随机对照试验(RCT)已经完成,该策略涉及在定期 ANC 就诊时使用快速诊断检测疟疾,并仅在检测结果为阳性时对妇女进行治疗,而不是采用 SP-IPT。本文报告了一项补充研究,该研究调查了不同策略对参加试验的妇女的可接受性。

方法

通过对从 RCT 的不同组随机选择的妇女进行的 12 次焦点小组讨论收集数据,探讨了她们对产前保健的经验和看法,以及对参与试验的看法。采用内容分析法确定相关主题以构建结果。

结果

从参与者的 ANC 经历和 RCT 中得出了五个主要主题,这些主题将影响她们对妊娠期间疟疾预防策略的可接受性:健康效益;接受的药物;接受的检查;接受的其他服务;以及卫生工作者的态度。自身和婴儿的健康是参加 ANC 的主要动机,并被认为是参加 RCT 的一个积极结果。妇女对药物或血液检查的生物医学功能并不总是清楚,但由于对卫生人员的强烈信任,她们通常会接受。工作人员的家访和作为试验一部分的免费 ITN 受到赞赏。工作人员的礼貌和耐心是一个非常积极的因素。

结论

总的来说,间歇性筛查和治疗以及间歇性预防治疗作为妊娠期间疟疾控制策略,对孕妇来说同样可以接受。与干预措施的性质相比,妇女更关心所接受的服务质量,特别是卫生人员的礼貌和耐心态度,以及对自己和婴儿的积极健康影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a171/2817700/b680d503f4e0/1475-2875-9-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a171/2817700/b680d503f4e0/1475-2875-9-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a171/2817700/b680d503f4e0/1475-2875-9-18-1.jpg

相似文献

1
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability.孕期疟疾间歇性筛查和治疗与间歇性预防治疗的比较:用户可接受性。
Malar J. 2010 Jan 14;9:18. doi: 10.1186/1475-2875-9-18.
2
The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.孕期间歇性筛查与治疗对比间歇性预防性治疗的可接受性:加纳北部一项定性研究的结果
Malar J. 2014 Nov 18;13:432. doi: 10.1186/1475-2875-13-432.
3
Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability.妊娠期间间歇性筛查和治疗与间歇性预防治疗疟疾:提供者的知识和可接受性。
PLoS One. 2011;6(8):e24035. doi: 10.1371/journal.pone.0024035. Epub 2011 Aug 24.
4
User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.肯尼亚西部间歇性筛查与治疗以及双氢青蒿素哌喹间歇性预防治疗预防疟疾在孕期的使用者和提供者的可接受性
PLoS One. 2016 Mar 17;11(3):e0150259. doi: 10.1371/journal.pone.0150259. eCollection 2016.
5
Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.马拉维孕期疟疾控制中间歇性筛查和治疗的提供者与使用者的可接受性。
Malar J. 2016 Nov 28;15(1):574. doi: 10.1186/s12936-016-1627-5.
6
Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women.在印度尼西亚东部,与目前针对孕妇疟疾的单次筛查和治疗的现行政策相比,间歇性筛查和治疗或间歇性预防治疗:卫生提供者和孕妇的可接受性。
Malar J. 2018 Sep 27;17(1):341. doi: 10.1186/s12936-018-2490-3.
7
Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.在尼日利亚进行的一项基于机构的、开放性标签、非劣效性试验:孕妇疟疾的青蒿琥酯-咯萘啶间歇性筛查和治疗与磺胺多辛-乙胺嘧啶间歇性预防治疗的比较。
Malar J. 2018 Jul 6;17(1):251. doi: 10.1186/s12936-018-2394-2.
8
Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.马拉维采用世界卫生组织更新的政策后,使用磺胺多辛-乙胺嘧啶进行间歇性预防治疗疟疾在孕妇中的应用:2015-2016 年人口与健康调查分析。
BMC Public Health. 2020 Mar 16;20(1):335. doi: 10.1186/s12889-020-08471-5.
9
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.在肯尼亚西部,采用双氢青蒿素哌喹进行间歇筛查和治疗或间歇预防性治疗与采用磺胺多辛-乙胺嘧啶进行间歇预防性治疗以控制孕期疟疾的比较:一项开放标签、三组、随机对照优势试验。
Lancet. 2015 Dec 19;386(10012):2507-19. doi: 10.1016/S0140-6736(15)00310-4. Epub 2015 Sep 28.
10
Coverage and efficacy of intermittent preventive treatment with sulphadoxine pyrimethamine against malaria in pregnancy in Côte d'Ivoire five years after its implementation.在科特迪瓦实施乙胺嘧啶-磺胺多辛间歇性预防治疗疟疾五年后的覆盖率及疗效。
Parasit Vectors. 2014 Nov 20;7:495. doi: 10.1186/s13071-014-0495-5.

引用本文的文献

1
Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study.在巴布亚新几内亚使用周效磺胺-乙胺嘧啶加双氢青蒿素-哌喹进行孕期疟疾间歇性预防治疗的可接受性:一项定性研究
Malar J. 2025 Jan 13;24(1):13. doi: 10.1186/s12936-024-05233-1.
2
Synthesis of Qualitative Evidence on Malaria in Pregnancy, 2005-2022: A Systematic Review.2005 - 2022年孕期疟疾定性证据的综合:一项系统评价
Trop Med Infect Dis. 2023 Apr 20;8(4):235. doi: 10.3390/tropicalmed8040235.
3
Perceptions of sulphadoxine-pyrimethamine use among pregnant women in sub-Saharan Africa: a scoping review.

本文引用的文献

1
Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar, Tanzania.坦桑尼亚桑给巴尔儿童单纯性疟疾采用青蒿琥酯-阿莫地喹联合疗法的依从性
Trop Med Int Health. 2009 Jul;14(7):766-74. doi: 10.1111/j.1365-3156.2009.02289.x. Epub 2009 Jun 17.
2
Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi.为什么个人会同意参加临床试验?对马拉维布兰太尔健康研究参与情况的定性研究。
Malawi Med J. 2008 Jun;20(2):37-41. doi: 10.4314/mmj.v20i2.10898.
3
The use of antenatal and postnatal care: perspectives and experiences of women and health care providers in rural southern Tanzania.
撒哈拉以南非洲地区孕妇对磺胺多辛-乙胺嘧啶使用情况的认知:一项范围综述
Malariaworld J. 2023 Apr 6;14:1. doi: 10.5281/zenodo.7828460. eCollection 2023.
4
Antenatal care positive responses to pregnant women in preventing and controlling malaria in pregnancy: the sub-Saharan African perspective.产前保健对撒哈拉以南非洲孕妇预防和控制妊娠疟疾的积极反应。
World J Pediatr. 2022 Jul;18(7):453-462. doi: 10.1007/s12519-022-00549-x. Epub 2022 May 26.
5
Acceptability and feasibility of malaria prophylaxis for forest goers: findings from a qualitative study in Cambodia.森林工作者疟疾预防措施的可接受性和可行性:柬埔寨定性研究的结果。
Malar J. 2021 Nov 25;20(1):446. doi: 10.1186/s12936-021-03983-w.
6
Intermittent screening and treatment with artemisinin-combination therapy versus intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria in pregnancy: a systematic review and individual participant data meta-analysis of randomised clinical trials.青蒿素联合疗法间歇性筛查和治疗与周效磺胺-乙胺嘧啶间歇性预防治疗用于孕期疟疾的比较:随机临床试验的系统评价和个体参与者数据荟萃分析
EClinicalMedicine. 2021 Oct 25;41:101160. doi: 10.1016/j.eclinm.2021.101160. eCollection 2021 Nov.
7
Healthcare provider and pregnant women's perspectives on the implementation of intermittent screening and treatment with dihydroartemisinin-piperaquine for malaria in pregnancy in western Kenya: a qualitative study.肯尼亚西部卫生保健提供者和孕妇对在妊娠期间使用二氢青蒿素-哌喹间歇性筛查和治疗疟疾的实施看法:一项定性研究。
Malar J. 2021 Jun 29;20(1):291. doi: 10.1186/s12936-021-03826-8.
8
Acceptability of single screening and treatment policy for the control of malaria in pregnancy: perceptions of providers and pregnant women from selected health facilities in Lindi region, Tanzania.在坦桑尼亚林迪地区,从选定的卫生机构中选取的提供者和孕妇对控制妊娠疟疾的单一筛查和治疗政策的可接受性:观念。
Malar J. 2021 Jun 8;20(1):256. doi: 10.1186/s12936-021-03782-3.
9
Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.在肯尼亚西部常规医疗体系下,采用双氢青蒿素-哌喹间歇性筛查和治疗预防妊娠疟疾的实施可行性。
Malar J. 2020 Nov 25;19(1):433. doi: 10.1186/s12936-020-03505-0.
10
Participation of Ghanaian pregnant women in an antimalarial drug trial: willingness, experiences and perceptions.加纳孕妇参与抗疟药物试验的意愿、经验和看法。
Trans R Soc Trop Med Hyg. 2021 Jun 2;115(6):714-719. doi: 10.1093/trstmh/traa120.
坦桑尼亚南部农村地区妇女及医疗服务提供者对产前和产后护理的使用情况:观点与经验
BMC Pregnancy Childbirth. 2009 Mar 4;9:10. doi: 10.1186/1471-2393-9-10.
4
Does Insecticide Treated Mosquito Nets (ITNs) prevent clinical malaria in children aged between 6 and 59 months under program setting?在项目实施环境下,经杀虫剂处理的蚊帐(ITNs)能否预防6至59个月大儿童的临床疟疾?
J Community Health. 2009 Apr;34(2):102-12. doi: 10.1007/s10900-008-9132-6.
5
The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.通过坦桑尼亚南部扩大免疫规划实施的婴儿间歇性预防疟疾治疗(IPTi)的可接受性。
Malar J. 2008 Oct 21;7:213. doi: 10.1186/1475-2875-7-213.
6
Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy.OptiMAL 试纸在妊娠疟疾感染诊断中的性能。
Ther Clin Risk Manag. 2008 Jun;4(3):631-6. doi: 10.2147/tcrm.s2809.
7
Community-based health insurance and access to maternal health services: evidence from three West African countries.基于社区的医疗保险与孕产妇保健服务的可及性:来自三个西非国家的证据
Soc Sci Med. 2008 Jun;66(12):2460-73. doi: 10.1016/j.socscimed.2008.01.044. Epub 2008 Mar 24.
8
Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites.基于青蒿素的联合疗法用于非洲四个地区疟疾家庭管理的可行性与可接受性
Malar J. 2008 Jan 8;7:6. doi: 10.1186/1475-2875-7-6.
9
Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review.周效磺胺-乙胺嘧啶耐药性对孕期疟疾控制间歇性预防治疗效果的影响:一项系统评价
JAMA. 2007 Jun 20;297(23):2603-16. doi: 10.1001/jama.297.23.2603.
10
Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children.青蒿琥酯-阿莫地喹联合疗法治疗加蓬幼儿恶性疟
Malar J. 2007 Mar 12;6:29. doi: 10.1186/1475-2875-6-29.